title: Transapical transcatheter treatment of a stenosed aortic valve bioprosthesis using the Edwards SAPIEN Transcatheter Heart Valve.
abstract: Transcatheter transapical or transfemoral aortic valve replacement has emerged as an alternative therapy of severe, symptomatic valvular aortic stenosis in surgically nonamenable patients. We report a transapical treatment of a severely stenosed 21-mm aortic Mitroflow valve bioprosthesis (Sorin Group, Vancouver, British Columbia, Canada) in an 82-year-old woman using a 23-mm Edwards SAPIEN Transcatheter Heart Valve (Edwards Lifesciences, Irvine, CA).
authors.affiliation: Department of Thoracic and Cardiovascular Surgery, Aarhus University Hospital, Skejby, Denmark.
authors.forename: Kaj-Erik
authors.initials: KE
authors.lastname: Klaaborg
authors.forename: Henrik
authors.initials: H
authors.lastname: Egeblad
authors.forename: Carl-Johan
authors.initials: CJ
authors.lastname: Jakobsen
authors.forename: Kim
authors.initials: K
authors.lastname: Terp
authors.forename: Christian
authors.initials: C
authors.lastname: Lindskov
authors.forename: Henning Rud
authors.initials: HR
authors.lastname: Andersen
authors.forename: Leif
authors.initials: L
authors.lastname: Thuesen
mesh_terms: D000369:Aged, 80 and over; D001024:Aortic Valve Stenosis / Q000601:surgery*; D001705:Bioprosthesis; D006328:Cardiac Catheterization; D005260:Female; D006350:Heart Valve Prosthesis; D006801:Humans; D011183:Postoperative Complications / Q000601:surgery*; D011474:Prosthesis Design